Abstract is: ChemRxiv (pronounced "chem archive"—the X represents the Greek letter chi [χ]) is an open access preprint archive for chemistry. It is operated by the American Chemical Society, Royal Society of Chemistry and German Chemical Society. The new preprint server was announced already in 2016, but was only opened online in 2017. Initially, editors of ACS journals were skeptical and only 80% of the editors allowed submissions to be uploaded to the preprint server in 2017. In 2019 the Chinese Chemical Society and the Chemical Society of Japan joined as co-owners of the preprint server. The initial reception of ChemRxiv was one of hesitation, with several major journals of the founding organizations initially unsupportive: Angewandte Chemie gave support in March 2018 and JACS only gave support in August 2018. However, ChemRxiv received more than 1,000 submissions in the first eighteen months.,growing to 2,314 in 2019. Like other preprint servers, it saw a surge in COVID-19 preprints in 2020.
| disciplinary repository | Q5281480 |
| preprint server | Q45787211 |
| P6180 | Dimensions Source ID | 1315496 |
| P2671 | Google Knowledge Graph ID | /g/11ggvyyskk |
| P236 | ISSN | 2573-2293 |
| P1055 | NLM Unique ID | 101720906 |
| P243 | OCLC control number | 1066058158 |
| P856 | official website | https://chemrxiv.org/ |
| P2002 | X username | ChemRxiv |
| P1619 | date of official opening | 2017-08-15 | |
| P1343 | described by source | Open Science Thesaurus | Q108928644 |
| Directory of Open Access Preprint Repositories | Q118384312 | ||
| P1889 | different from | arXiv | Q118398 |
| P571 | inception | 2016-01-01 | |
| P8687 | social media followers | 24782 | |
| P1687 | Wikidata property | ChemRxiv ID | P9262 |
| Q102129673 | A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual Screening |
| Q97530798 | A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19 |
| Q98467266 | A Rational Design of a Multi-Epitope Vaccine Against SARS-CoV-2 Which Accounts for the Glycan Shield of the Spike Glycoprotein |
| Q89100122 | A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry |
| Q97530808 | Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2 |
| Q123537574 | Alloying and Phase Transformation of Fe/FeNi Core/Alloy Nanoparticles at High Temperatures |
| Q96223141 | An Online Repository of Solvation Thermodynamic and Structural Maps of SARS-CoV-2 Targets |
| Q103837480 | COVID-19 knowledge extractor (COKE): a tool and a web portal to extract drug-target protein associations from the CORD-19 corpus of scientific publications on COVID-19 |
| Q96817963 | COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database |
| Q96223135 | Computational Models Identify Several FDA Approved or Experimental Drugs as Putative Agents Against SARS-CoV-2 |
| Q96223143 | Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins |
| Q102129682 | Copper(II) Inhibition of the SARS-CoV-2 Main Protease |
| Q93847384 | DeepSMILES: An Adaptation of SMILES for Use in Machine-Learning of Chemical Structures |
| Q104931192 | Enantioselective conjugate addition of catalytically generated zinc homoenolate |
| Q96909013 | Extension of Roles in the ChEBI Ontology |
| Q93855575 | Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study |
| Q93850725 | Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells |
| Q93846336 | Knowledge-Based Structural Models of SARS-CoV-2 Proteins and Their Complex with Potential Drugs |
| Q99552288 | LCMS Measurement of Steroid Biomarkers Collected from Palmar Sweat |
| Q93851982 | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV |
| Q102129683 | REDIAL-2020: A Suite of Machine Learning Models to Estimate Anti-SARS-CoV-2 Activities |
| Q93853160 | RISC and Dense Fingerprints |
| Q111154340 | Scaffold Generator - A Java library implementing molecular scaffold functionalities in the Chemistry Development Kit (CDK) |
| Q96223132 | Shotgun drug repurposing biotechnology to tackle epidemics and pandemics |
| Q96223145 | Structural Similarity of SARS-CoV2 Mpro and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics |
| Q98577324 | Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: a tutorial for students and scientists |
| Q102129677 | Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19 |
| Q89400530 | The chemfp Project |
| Q102129670 | Tuning Proton Transfer Thermodynamics in SARS-Cov-2 Main Protease: Implications for Catalysis and Inhibitor Design |
| Q93853494 | Visualization of Very Large High-Dimensional Data Sets as Minimum Spanning Trees |
| Q93842984 | mmpdb: An Open Source Matched Molecular Pair Platform for Large Multi-Property Datasets |
| Q38376889 | ChemRXiv: A Chemistry Preprint Server |
| Q57998675 | ChemRxiv: Year One and Beyond [Editorial] |
| Q116113662 | Five Years of ChemRxiv: Where We Are and Where We Go from Here |
| Q50013935 | OPEN ACCESS. Chemists to get preprint server of their own. |
| Q118398 | arXiv | different from | P1889 |
| P9262 | ChemRxiv ID | issued by | P2378 |
| P9262 | ChemRxiv ID | applicable 'stated in' value | P9073 |
| Catalan (ca / Q7026) | ChemRxiv | wikipedia |
| ChemRxiv | wikipedia | |
| ChemRxiv | wikipedia | |
| ChemRxiv | wikipedia |
Search more.